Parkinson’s disease is considered the second most common degenerative disease of the central nervous system.

It is a rare disease among children and adolescents, being common between 50 and 79 years old, and with prevalence in men. It is estimated that there are about 7 to 10 million individuals with the disease, with about 5% of cases appearing before the age of 40.

Parkinson’s disease is a degenerative and slowly progressive disease of specific areas of the brain. It is characterized by tremor when the muscles are at rest (resting tremor), increased muscle tone (stiffness), sluggish voluntary movements and difficulty maintaining balance (postural instability). In many people, thinking becomes compromised or dementia develops.

Current scientific research is focused on identifying potential biomarkers of the disease, which allow an accurate and timely diagnosis, and on the creation of more effective therapies, in order to fill the currently unmet clinical needs.

Alzheimer’s disease is the most common form of dementia, causing a global, progressive and irreversible deterioration of several cognitive functions, including memory, attention, concentration, language and thinking.

According to the World Health Organization, about 60 to 70% of all cases of dementia belong to Alzheimer’s disease.

There are an estimated 193,000 Alzheimer’s patients in Europe, with 47.5 million cases of dementia.

So far there is no cure for this disease. However, there are some medications that help stabilize cognitive functions in people in the mild to moderate stages.